3,081 Shares in Exponent, Inc. (NASDAQ:EXPO) Purchased by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC bought a new position in shares of Exponent, Inc. (NASDAQ:EXPO) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 3,081 shares of the business services provider’s stock, valued at approximately $293,000.

Several other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Exponent by 5.8% during the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after acquiring an additional 291,047 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its position in Exponent by 6.5% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock valued at $441,414,000 after purchasing an additional 284,179 shares in the last quarter. Conestoga Capital Advisors LLC raised its position in Exponent by 2.8% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,763,260 shares of the business services provider’s stock valued at $262,841,000 after purchasing an additional 75,909 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Exponent by 0.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,019,085 shares of the business services provider’s stock valued at $96,937,000 after purchasing an additional 6,108 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in Exponent by 3.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 534,520 shares of the business services provider’s stock valued at $50,844,000 after purchasing an additional 17,849 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Analyst Ratings Changes

Separately, Truist Financial reaffirmed a “buy” rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Price Performance

EXPO stock opened at $113.06 on Tuesday. The firm has a market capitalization of $5.73 billion, a P/E ratio of 57.10 and a beta of 0.66. The business’s 50-day moving average is $107.99 and its two-hundred day moving average is $98.48. Exponent, Inc. has a 1 year low of $64.61 and a 1 year high of $115.61.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The business had revenue of $132.43 million for the quarter, compared to the consensus estimate of $130.83 million. During the same quarter in the prior year, the business posted $0.50 EPS. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. On average, analysts expect that Exponent, Inc. will post 2.04 EPS for the current year.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were issued a $0.28 dividend. The ex-dividend date was Friday, September 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.99%. Exponent’s payout ratio is currently 56.57%.

Insider Activity

In other news, VP John Pye sold 3,956 shares of the stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now owns 28,422 shares in the company, valued at approximately $2,984,310. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 2.10% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.